Self‐administration of cocaine and the cocaine analog RTI‐113: Relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys
- 30 October 2001
- Vol. 43 (1) , 78-85
- https://doi.org/10.1002/syn.10018
Abstract
Dopaminergic mechanisms are thought to play a central role in the reinforcing effects of cocaine. The present study examined the reinforcing effects of 3β-(4-chlorophenyl)tropane-2β-carboxylic acid phenyl ester (RTI-113), a long-acting, selective, high-affinity dopamine uptake inhibitor. Additionally, the effects of RTI-113 pretreatment on cocaine self-administration were determined. Monkeys were trained to respond under a second-order schedule for intravenous cocaine administration (0.10 or 0.17 mg/kg/infusion). When responding was stable, cocaine (0.0030–1.0 mg/kg/infusion) and RTI-113 (0.010–0.30 mg/kg/infusion) were substituted for the cocaine training dose. Cocaine and RTI-113 were equipotent for their reinforcing effects. However, cocaine maintained higher response rates in two of the three monkeys tested. When administered as a pretreatment, RTI-113 (0.10–0.30 mg/kg) dose-dependently reduced responding maintained by two doses of cocaine. Drug effects on behavior were related to dopamine transporter (DAT) occupancy in monkey striatum during neuroimaging with positron emission tomography. DAT occupancy was determined by displacement of 8-(2-[18F]fluroethyl)2β-carbomethoxy-3β-(4-chlorophenyl)nortropane (FECNT). DAT occupancy was between 65–76% and 94–99% for doses of cocaine and RTI-113 that maintained maximum response rates, respectively. DAT occupancy did not differ markedly across RTI-113 pretreatment doses and ranged between 72–84%. The results suggest that the pharmacokinetic profile of RTI-113 (i.e., long-acting) may influence its ability to maintain self-administration, and therefore its abuse liability. Additionally, high DAT occupancy is required for RTI-113 to reduce cocaine-maintained responding. Synapse 43:78–85, 2002.Keywords
This publication has 30 references indexed in Scilit:
- Pharmacotherapies for Treatment of Cocaine Abuse: Preclinical AspectsJournal of Medicinal Chemistry, 1999
- Cocaine and 3.beta.-(4'-Substituted phenyl)tropane-2.beta.-carboxylic Acid Ester and Amide Analogs. New High-Affinity and Selective Compounds for the Dopamine TransporterJournal of Medicinal Chemistry, 1995
- Synthesis of 2.beta.-Acyl-3.beta.-aryl-8-azabicyclo[3.2.1]octanes and Their Binding Affinities at Dopamine and Serotonin Transport Sites in Rat Striatum and Frontal CortexJournal of Medicinal Chemistry, 1994
- Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeysDrug and Alcohol Dependence, 1993
- Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat striatumEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporterPharmacology Biochemistry and Behavior, 1992
- GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopaminePharmacology Biochemistry and Behavior, 1991
- The dopamine hypothesis of the reinforcing properties of cocaineTrends in Neurosciences, 1991
- Combination of Dynamic and Integral Methods for Generating Reproducible Functional CBF ImagesJournal of Cerebral Blood Flow & Metabolism, 1990
- Mapping cocaine binding sites in human and baboon brain in vivoSynapse, 1989